TERIPARATIDE TEVA

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Kupi sada

Preuzimanje Uputa o lijeku (PIL)
01-03-2023

Aktivni sastojci:

TERIPARATIDE AS ACETATE

Dostupno od:

ABIC MARKETING LTD, ISRAEL

ATC koda:

H05AA02

Farmaceutski oblik:

SOLUTION FOR INJECTION

Sastav:

TERIPARATIDE AS ACETATE 250 MCG/ML

Administracija rute:

S.C

Tip recepta:

Required

Proizveden od:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

Područje terapije:

TERIPARATIDE

Terapijske indikacije:

Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture:Teriparatide Teva is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Teriparatide Teva increases BMD reduces the risk of vertebral and nonvertebral fractures . Increase of Bone Mass in Men with Primary or Hypogonadal Osteoporosis at High Risk for Fracture :Teriparatide Teva is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . Treatment of Men and Women with Glucocorticoid-Induced Osteoporosis at High Risk for Fracture:Teriparatide Teva is indicated for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy

Datum autorizacije:

2020-01-08

Uputa o lijeku

                                ّ
لحلا ةلكشملا
لصاو .فقوتي نأ ىلإ لخادلا وحن دوسلأا
نقحلا رز عفدا .غراف ءاعو هاجتاب لفسلأا
وحن ةربلإا ه
ْ
ّ
جو .4
.رزلا ىلع طغضلا
دوسلأا نقحلا رز نوكي نأ بجي ،يهتنت نأ
دعب .لئاسلا نم ةرطق وأ ةليلق ةيمك قفدت
دهاشت دق
."ةربلإا جرخأ" 6 ةلحرملا ىلإ عبات
.هتياهن ىتح لخادلا وحن اطوغضم
.يلديصلا وأ بيبطلاب لصتا ،رفصلأا
ضبقملا ىرت تلز ام اذإ .5
.ةيمويلا نقحلا تاعرج نادقف ىلإ عڤيت
دياتارابيريت ملق طبض ةداعإ يدؤت دق ،حيحص لكشب ةربلإا ليصوت نم دكأتلاو
،ةنقح لك يف ةديدج ةربإ لامعتساب
ةلكشملا هذه يدافت نكمي
.ةياهنلا ىتح لخادلا ىلإ دوسلأا نقحلا
رز ىلع طغضلا قيرط نعو
:ةيلاتلا لحارملا عبتا ،عڤيت
دياتارابيريت ملق طبض ةداعإ فدهب
.مويلا تاذ يف ىرخأ ةرم ءاودلا نقحت لاف
،ءاودلا نقح تيهنأ اذإ .1
.ةربلإا عزنا .2
.مدختسملا ليلد يف "ةعرجلا دادعإ" 3
ةلحرملاو "ةديدج ةربإ ل
ِ
ص" 2 ةلحرملا ر
ّ
رك .3 .أ دعب ارهاظ رفصلأا ضبقملا لاز ام .دوسلأا نقحلا رز ىلع تطغض نأ دياتارابيريت ملق طبض يننكمي فيك
؟يب صاخلا عڤيت
.عڤيت دياتارابيريت ملق نم لماكلاب
ةعرجلا نقح مت هنأ ىلإ ريشي ام ،ةياهنلا
ىتح لخادلا وحن اطوغضم دوسلأا نقحلا رز
نوكي نأ ضرتف
ُ
ي
.يغبني امك كب صاخلا عڤيت دياتارابيريت
ملق لمعي نأ نامضل ةعرجلا اهيف نقحت ةرم
لك يف ةديدج ةربإ لمعتسا .ب صاخلا عڤيت دياتارابيريت ملق ن
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku arapski 01-03-2023
Uputa o lijeku Uputa o lijeku hebrejski 01-03-2023

Upozorenja za pretraživanje vezana za ovaj proizvod

Pogledajte povijest dokumenata